NHS National Generic Pharmaceuticals- Transition 2021_1
Estimated value
£8.9m
Awarded value
£8.9m
Suppliers
1
Lots
1
Published
29 Apr 2021
Description
NHS National PharmaceuticalsTransition 2021_1 Offer referencenumber: CM/PHG/20/5629 Period offramework agreement: the totalmaximum duration of the frameworkagreement to be no more than 29months (14.5 months plus options toextend (at the Authority's solediscretion) for up to a further 14.5months) Potential Periods of call-offsunder the framework agreementTransition and 33 % Products: CESW 15 April 2021 to 30 September2021 (5.5 months); LSNE 15 April 2021 to 28 February2022 (10.5 months); NWLN 15 April 2021 to 30 June 2022(14.5 months); 100 % Products (All Regions): 15 April2021 to 28 February 2022 (10.5months).
Scope
- Reference
- CF-0180900D0O000000rwimUAA1
- Total value
- £8,858,050 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 14 Apr 2021 to 29 Jun 2022
- CPV classifications
- 33600000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 07 Jan 2021, 1:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£8.9m
Award date
03 Mar 2021
Contract start
14 Apr 2021
Contract end
29 Jun 2022